Clinical trial
A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo…
NCT00126399 · CollaGenex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00126399 |
|---|---|
| Title | A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea |
| Lead sponsor | CollaGenex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rosacea |
| Intervention type | Drug |
| Interventions | doxycycline |
| Enrollment | 528 |
| Start date | Jun 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Aug 4, 2005 |
| Last update posted | Aug 19, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: